Matthew Hammond - Net Worth and Insider Trading

Matthew Hammond Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Hammond owns 3 companies in total, including Therapeutics Acquisition Corp (RACA) , POINT Biopharma Global Inc (PNT) , and Research Alliance Corp II (RACB) .

Click here to see the complete history of Matthew Hammond’s form 4 insider trades.

Insider Ownership Summary of Matthew Hammond

Ticker	Comapny	Transaction Date	Type of Owner
RACA	Therapeutics Acquisition Corp	2020-07-07	director & Chief Financial Officer
PNT	POINT Biopharma Global Inc	2020-07-07	director & Chief Financial Officer
RACB	Research Alliance Corp II	2021-03-17	director & Chief Investment Officer

Matthew Hammond Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Hammond Ownership Network

Ownership Network List of Matthew Hammond

No Data

Ownership Network Relation of Matthew Hammond

Matthew Hammond Owned Company Details

What does Therapeutics Acquisition Corp do?

Who are the key executives at Therapeutics Acquisition Corp?

Matthew Hammond is the director & Chief Financial Officer of Therapeutics Acquisition Corp. Other key executives at Therapeutics Acquisition Corp include director & Chief Executive Officer Peter Kolchinsky , and 10 percent owner Therapeutics Acquisition Holdings Llc .

Therapeutics Acquisition Corp (RACA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Therapeutics Acquisition Corp (RACA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Therapeutics Acquisition Corp (RACA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Therapeutics Acquisition Corp (RACA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Therapeutics Acquisition Corp Insider Transactions

No Available Data

What does POINT Biopharma Global Inc do?

Who are the key executives at POINT Biopharma Global Inc?

Matthew Hammond is the director & Chief Financial Officer of POINT Biopharma Global Inc. Other key executives at POINT Biopharma Global Inc include other: See Explanation of Responses Biotechnology Value Fund L P , 10 percent owner Bvf Partners L P/il , and 10 percent owner Bvf Gp Holdings Llc .

POINT Biopharma Global Inc (PNT) Insider Trades Summary

Over the past 18 months, Matthew Hammond made no insider transaction in POINT Biopharma Global Inc (PNT). Other recent insider transactions involving POINT Biopharma Global Inc (PNT) include a net sale of 17,161,278 shares made by Biotechnology Value Fund L P ,

In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc (PNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,161,278 shares of POINT Biopharma Global Inc (PNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,161,278 shares.

POINT Biopharma Global Inc (PNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

POINT Biopharma Global Inc Insider Transactions

No Available Data

What does Research Alliance Corp II do?

Who are the key executives at Research Alliance Corp II?

Matthew Hammond is the director & Chief Investment Officer of Research Alliance Corp II. Other key executives at Research Alliance Corp II include 10 percent owner Saba Capital Management, L.p. , 10 percent owner Boaz Weinstein , and director & Chief Executive Officer Peter Kolchinsky .

Research Alliance Corp II (RACB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Research Alliance Corp II (RACB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Research Alliance Corp II (RACB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Research Alliance Corp II (RACB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Research Alliance Corp II Insider Transactions

No Available Data

Matthew Hammond Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Hammond. You might contact Matthew Hammond via mailing address: 200 Berkeley Street, 18th Floor, Boston Ma 02116.

Discussions on Matthew Hammond

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.